Pharmacological characterization and determination of pharmacokinetic and pharmacodynamic relationship of PF-00885706, a novel partial agonist selective for the 5-HT4 receptor
Tohru Komada(Pfizer (Japan)), Hiroyuki Eda(Pfizer (Japan)), Hiromi Sugimoto(Pfizer (Japan)), Naoji Kimura(Pfizer (Japan)), Tadayoshi Mikami(Pfizer (Japan)), Yasuhiro Nakai(Pfizer (Japan)), Tomomi Matsuura(Keio University), Takashi Ohmi(Pfizer (Japan)), Tetsuo Toga(Pfizer (Japan))
Cited by 2
Related Papers
Distinct Metabolic Flow Enables Large-Scale Purification of Mouse and Human Pluripotent Stem Cell-Derived Cardiomyocytes
|Cell stem cell|2012|1.1k
Glutamine Oxidation Is Indispensable for Survival of Human Pluripotent Stem Cells
|Cell Metabolism|2016|252
Reduced methylation of PFKFB3 in cancer cells shunts glucose towards the pentose phosphate pathway
|Nature Communications|2014|250
Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus
|Diabetology & Metabolic Syndrome|2017|187
A defect of LigD (human Lig4 homolog) for nonhomologous end joining significantly improves efficiency of gene-targeting in Aspergillus oryzae
|Fungal Genetics and Biology|2008|176